Area of research
Pharmacology · Global and Planetary Change
Research interest
Research interests include Cannabis and Cannabinoid Research, Marine and fisheries research, Schizophrenia research and treatment, and Fish Ecology and Management Studies.
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial
Exploring causal mechanisms of psychosis risk
The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios
The impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder and bipolar affective disorder: An electronic case register cohort study
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products
Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study
Improving life expectancy in people with serious mental illness: Should we place more emphasis on primary prevention?
Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?